ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib by Thunnissen, E., Lissenberg-Witte, B.I., van den Heuvel, M.M., Monkhorst, K., Skov, B.G., Sørensen, J.B., Mellemgaard, A., Dingemans, A.M.C., Speel, E.J.M., de Langen, A.J., Hashemi, S.M.S., Bahce, I., van der Drift, M.A., Looijen-Salamon, M.G., Gosney, J., Postmus, P.E., Samii, S.M.S., Duplaquet, F, Weynand, B., Durando, X., Penault-Llorca, F., Finn, S., Grady, A.O, Oz, B., Akyurek, N., Buettner, R., Wolf, J., Bubendorf, L., Duin, S., Marondel, I., Heukamp, L.C., Timens, W., Schuuring, E.M.D., Pauwels, P., Smit, E.F.

Get full text